Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue

Bulletin of Mathematical Biology

Volumn 64, Issue 1, 2002, Pages 97-131

  Albanese, R A ^a   Banks, H T ^b   Evans, M V ^c   Potter, L K ^b  

^a AIR FORCE RESEARCH LABORATORY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRICHLOROETHYLENE;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BIOACCUMULATION; BLOOD FLOW; COMPARTMENT MODEL; HUMAN; NONHUMAN; SIMULATION;

ANIMALIA;

EID: 0036379747     PISSN: 00928240     EISSN: None     Source Type: Journal    
DOI: 10.1006/bulm.2001.0268     Document Type: Article

References (52)

1. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichlorocetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice
2. Total DDT and dieldrin content of human adipose-tissue
3. Remarks on uncertainty of assessment and management in modeling and computation
4. Modeling and estimating uncertainty in parameter estimation
5. Predictions for a distributed parameter model describing the hepatic processing of 2,3,7,8-TCDD
6. A dispersion model for the hepatic uptake and elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin
7. Evaluating noncancer effects of trichloroethylene: Dosimetry, mode of action, and risk assessment
8. Application and results of whole-body autoradiography in distribution studies of organic solvents
9. Continuity of intracellular channels with extracellular space in adipose tissue and liver: Demonstrated with tannic acid and lanthanum
10. Lipolysis and lamellar structures in white adipose tissue of young rats: Lipid movement in membranes
11. Membrane continuities within cells and intercellular contacts in white adipose tissue of young rats
12. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma
13. Metabolism, toxicity, and carcinogenicity of trichloroethylene
14. Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate
15. A CFD-PBPK hybrid model for simulating gas and vapor uptake in the rat nose
16. The toxicological significance of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds in adipose tissue
17. Hemodynamic and metabolic correlates in adipose tissue: Pathophysiologic considerations
18. A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives
19. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics
20. Uptake in vitro of lipophilic model compounds into adipose tissue preparations and lipids
21. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse
22. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol
23. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway
24. Pulmonary toxicity and carcinogenicity of trichloroethylene: Species differences and modes of action
25. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice
26. The comparative anatomy of adipose tissue
27. Metabolism of trichloroethylene
28. Modes of action of trichloroethylene for kidney tumorigenesis
29. Semivolatile organic compounds in adipose tissue: Estimated averages for the US population and selected subpopulations
30. Vascularization in adipose depots surrounding immune-stimulated lymph nodes
31. Adipose-tissue storage of drugs as a function of binding competition-in vitro studies with distribution dialysis
32. Human variability and susceptibility to trichloroethylene
33. A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations
34. Blood circulation in adipose tissue
35. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds
36. Developmental toxicity of trichloroethylene, tetrachloroethylene and four of their metabolites in rat whole embryo culture
37. Trichloroethylene health risks-state of the science
38. Transport of lipid across capillary endothelium
39. The effective magnetic properties of magnetorheological fluids
40. Estimation of the effective permeability in magnetorheological fluids
41. Physiologically-based pharmacokinetic models for trichloroethylene considering enterohepatic recirculation of major metabolites
42. Adipocyte blood flow is decreased in obese Zucker rats